Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Velosulin BR (Human Buffered Regular Insulin (rDNA origin)) Injection
Company:  Novo Nordisk Pharmaceuticals, Inc.
Application No.:  021-028
Approval Date: 7/19/1999


Date created: March 30, 2001

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.